Back to Markets
OROramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc

ORMPNASDAQ NMS - GLOBAL MARKET
Health CarePharmaceuticals

$3.97

+0.0100 (+0.25%)

As of 05/29/26 EDT · USD

Compare
Low: $1.84Current: $3.97High: $5.01

Key Statistics

Open

$3.96

Day High

$4.05

Day Low

$3.90

Prev. Close

$3.96

VolumeShares traded today.

121.20K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$162.48M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

1.53

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$5.01

52W LowLowest price over the past 52 weeks.

$1.84

50D MAAverage closing price over the last 50 trading days.

$3.87

200D MAAverage closing price over the last 200 trading days.

$3.06

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-9.4%

1M

+3.4%

6M

+37.8%

YTD

+36.4%

1Y

+66.8%

About

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

oramed.com/

Company Facts

SectorHealth Care
IndustryPharmaceuticals
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ORMP

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.